Fulgent Genetics, Inc. (FLGT)

Last Closing Price: 14.88 (2026-03-09)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Fulgent Genetics, Inc. (FLGT) had Net Income of $-60.51M for the most recently reported fiscal year, ending 2025-12-31.

Figures for fiscal year ending 2025-12-31
Income Statement Financials
$322.67M
Net Income
$-60.51M
$191.80M
$130.88M
$413.77M
$-91.10M
$21.07M
$-70.03M
$-60.10M
$-61.63M
$-61.63M
$-61.63M
$-50.52M
$-91.10M
$-72.08M
30.78M
30.78M
$-1.97
$-1.97
Balance Sheet Financials
$550.49M
$112.55M
$663.03M
$1.21B
$84.97M
--
$21.84M
$106.81M
$1.11B
$1.02B
$1.11B
31.08M
Cash Flow Statement Financials
$-101.64M
$111.37M
$-14.79M
$55.28M
$50.33M
$-4.95M
$39.58M
--
--
Fundamental Metrics & Ratios
6.48
--
--
--
0.00
40.56%
-28.23%
-28.23%
-22.34%
-21.70%
-18.75%
$-124.21M
--
--
--
0.27
--
3.81
95.88
-5.57%
-6.06%
-5.08%
-5.57%
$35.61
$-4.04
$-3.30